Nicotine effects on LPS-induced NF-capaB in the central nervous system / Efeito da nicotina na ativação do fator de transcrição NF-B no sistema nervoso central na vigência de estímulo inflamatório induzido por lipopolissacarídeo (LPS)
AUTOR(ES)
Cecilia Cerqueira Café Mendes
DATA DE PUBLICAÇÃO
2009
RESUMO
Nicotine is an alkaloid extracted from Tobacco plants, and it acts as an agonist in neurons and other cells that express nicotinic receptors. This substance crosses the blood brain barrier and mimics endogenous acetylcholine in interacting with various receptor subtypes. The hippocampus and cerebellum are brain regions rich in nicotinic receptors including 7, 42 and other subtypes, involved in neurodegenerative and neuropsychiatric disorders, including Alzheimer disease and schizophrenia, respectively, in a neuroinflammatory context. The lipopolysaccharide (LPS) is a known inflammatory inducer that exerts its effects through the Toll-like receptor 4 (TLR-4) and activates the transcription factor NF-capaB. In the present work, we evaluate the effects of chronic nicotine on the nuclear translocation of NF-capaB, on the expression of NF-capaB regulated inflammatory inducers (TNF, IL-1 and iNOS) and on the LPS-induced TLR4 mRNA expression in response to chronic nicotine treatment in hippocampus and cerebellum. In addition, we accessed the production of peripheral cytokines (TNF, IL-1, MIP-1, CINC 2/). Our results demonstrate that LPS induced the production of peripheral cytokines but nicotine treatment did not interfere in their plasma levels. However, in cerebellum and hippocampus, chronic nicotine 1.0 and 0.1 mg/kg interfered in the LPS-induced NF-capaB leading to a deficient mRNA expression of its related genes TNF, IL-1 and iNOS in hippocampus and of IL-1, in cerebellum. Chronic nicotine (0.1 mg/kg, s.c.) significantly interfered in the TLR4 mRNA expression in LPS-challenged animal group in hippocampus. The non-selective heteromeric antagonist mecamylamine (1.0 mg/kg s.c.) reverted the nicotine effects over NF-capaB nuclear translocation in cerebellum, but not in hippocampus. On the other hand, the 7 antagonist methyllycaconitine (MLA) (5.0 mg/kg i.p.) reverted the nicotine effects over NF-capaB in hippocampus but not in cerebellum. Nicotine prevents LPS effects, both in cerebellum and hippocampus, once it reduced significantly the nuclear translocation of NF-capaB and the expression of related pro-inflammatory cytokines. Besides, the nicotinic effects seem to be mainly mediated by heteromeric receptors in cerebellum and through 7 receptors in hippocampus.
ASSUNTO(S)
nicotina nicotine receptores nicotínicos lipopolissacarídeos inflamação inflammation nf-kappa b central nervous system sistema nervoso central nf-kappa b lipopolysaccharides receptors nicotinic
Documentos Relacionados
- NF-κB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation
- Metabolismo de triptofano na vigência de choque endotóxico induzido por LPS e hipertriptofanemia
- Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages.
- Influence of Synthetic Antiendotoxin Peptides on Lipopolysaccharide (LPS) Recognition and LPS-Induced Proinflammatory Cytokine Responses by Cells Expressing Membrane-Bound CD14
- Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages